Literature DB >> 19563837

Gumming up the works: DNA polymers as HCV entry inhibitors.

Natalie A Counihan, Brett D Lindenbach.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19563837      PMCID: PMC2939359          DOI: 10.1053/j.gastro.2009.06.018

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  26 in total

1.  L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus.

Authors:  Jason P Gardner; Robert J Durso; Robert R Arrigale; Gerald P Donovan; Paul J Maddon; Tatjana Dragic; William C Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-03       Impact factor: 11.205

2.  DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2.

Authors:  Pierre-Yves Lozach; Hugues Lortat-Jacob; Agnès de Lacroix de Lavalette; Isabelle Staropoli; Steven Foung; Ali Amara; Corinne Houles; Frank Fieschi; Olivier Schwartz; Jean-Louis Virelizier; Fernando Arenzana-Seisdedos; Ralf Altmeyer
Journal:  J Biol Chem       Date:  2003-02-27       Impact factor: 5.157

3.  Binding of hepatitis C virus to CD81.

Authors:  P Pileri; Y Uematsu; S Campagnoli; G Galli; F Falugi; R Petracca; A J Weiner; M Houghton; D Rosa; G Grandi; S Abrignani
Journal:  Science       Date:  1998-10-30       Impact factor: 47.728

4.  Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate.

Authors:  Heidi Barth; Christiane Schafer; Mohammed I Adah; Fuming Zhang; Robert J Linhardt; Hidenao Toyoda; Akiko Kinoshita-Toyoda; Toshihiko Toida; Toin H Van Kuppevelt; Erik Depla; Fritz Von Weizsacker; Hubert E Blum; Thomas F Baumert
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

5.  Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor.

Authors:  Birke Bartosch; Alessandra Vitelli; Christelle Granier; Caroline Goujon; Jean Dubuisson; Simona Pascale; Elisa Scarselli; Riccardo Cortese; Alfredo Nicosia; François-Loïc Cosset
Journal:  J Biol Chem       Date:  2003-08-11       Impact factor: 5.157

6.  CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.

Authors:  Jie Zhang; Glenn Randall; Adrian Higginbottom; Peter Monk; Charles M Rice; Jane A McKeating
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

7.  Potent antiscrapie activities of degenerate phosphorothioate oligonucleotides.

Authors:  David A Kocisko; Andrew Vaillant; Kil Sun Lee; Kevin M Arnold; Nadine Bertholet; Richard E Race; Emily A Olsen; Jean-Marc Juteau; Byron Caughey
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

8.  L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus.

Authors:  Emmanuel G Cormier; Robert J Durso; Fotini Tsamis; Lise Boussemart; Catherine Manix; William C Olson; Jason P Gardner; Tatjana Dragic
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-15       Impact factor: 11.205

9.  CD81 is an entry coreceptor for hepatitis C virus.

Authors:  Emmanuel G Cormier; Fay Tsamis; Francis Kajumo; Robert J Durso; Jason P Gardner; Tatjana Dragic
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-03       Impact factor: 11.205

10.  C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles.

Authors:  Pierre-Yves Lozach; Ali Amara; Birke Bartosch; Jean-Louis Virelizier; Fernando Arenzana-Seisdedos; François-Loïc Cosset; Ralf Altmeyer
Journal:  J Biol Chem       Date:  2004-05-27       Impact factor: 5.157

View more
  2 in total

1.  Oligonucleotides designed to inhibit TLR9 block Herpes simplex virus type 1 infection at multiple steps.

Authors:  Monica M Sauter; Joshua J L Gauger; Curtis R Brandt
Journal:  Antiviral Res       Date:  2014-07-01       Impact factor: 5.970

Review 2.  Targeting cell entry of enveloped viruses as an antiviral strategy.

Authors:  Elodie Teissier; François Penin; Eve-Isabelle Pécheur
Journal:  Molecules       Date:  2010-12-30       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.